Literature DB >> 20656319

Anaplastic sarcoma of the kidney with chromosomal abnormality: first report on cytogenetic findings.

Kiyoshi Gomi1, Satoshi Hamanoue, Mio Tanaka, Masae Matsumoto, Norihiko Kitagawa, Tetsu Niwa, Noriko Aida, Hisato Kigasawa, Yukichi Tanaka.   

Abstract

We report a case of anaplastic sarcoma of the kidney (ASK) with cytogenetic findings. A 12-year-old Japanese girl presented with buttock pain and urinary incontinence. Radiological investigations revealed a right renal tumor with multiple distant metastases and multicystic thyroid tumor. She underwent radical right nephrectomy and subsequently received chemotherapy and radiation therapy. Histologically, the renal tumor demonstrated admixture of various types of mesenchymal elements: cellular spindle cells with anaplastic features, cartilage, and rhabdomyoblastic cells consistent with ASK. Chromosomal analysis revealed the karyotype of the tumor cells to be 46, XX, +8, -10, der (18) t (10; 18) (q21; p11.2). The thyroid tumor was removed later and diagnosed as adenomatous goiter. To our knowledge, this is the first case of ASK with chromosomal abnormality and may provide new insight into the molecular biologic basis of this rare renal tumor.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20656319     DOI: 10.1016/j.humpath.2010.03.008

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  2 in total

1.  Expanding the spectrum of dicer1-associated sarcomas.

Authors:  Mikako Warren; Matthew C Hiemenz; Ryan Schmidt; Jared Shows; Jennifer Cotter; Stephanie Toll; David M Parham; Jaclyn A Biegel; Leo Mascarenhas; Rachana Shah
Journal:  Mod Pathol       Date:  2019-09-19       Impact factor: 7.842

2.  Anaplastic sarcomas of the kidney are characterized by DICER1 mutations.

Authors:  Mona K Wu; Gordan M Vujanic; Somayyeh Fahiminiya; Noriko Watanabe; Paul S Thorner; Maureen J O'Sullivan; Marc R Fabian; William D Foulkes
Journal:  Mod Pathol       Date:  2017-09-01       Impact factor: 7.842

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.